<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02764008</url>
  </required_header>
  <id_info>
    <org_study_id>AUTF ANESTHESIA2</org_study_id>
    <nct_id>NCT02764008</nct_id>
  </id_info>
  <brief_title>The Comparison of Low Thoracic Paravertebral Block Versus Peritubal Infiltration</brief_title>
  <official_title>The Comparison of Low Thoracic Paravertebral Block Versus Peritubal Infiltration in Patients Undergoing Percutaneous Nephrolithotomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ataturk University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ataturk University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Percutaneous nephrolithotomy (PCNL) is a safe and effective procedure that is considered the
      standard treatment for large and complex renal stones. Although it has lower complication and
      morbidity rates than open surgery, the pain and discomfort related to a nephrostomy tube can
      cause distress for patients.

      Managing this pain with opioids can lead to sedation, nausea, vomiting, and constipation,
      which defeat the purpose of this minimally invasive procedure.

      Skin infiltration with bupivacaine around the nephrostomy tube is not effective. Infiltration
      of renal capsule has shown to facilitate painless insertion of nephrostomy tube, suggesting
      the role of renal capsule in pain management.

      Peritubal infiltration of bupivacaine from renal capsule to the skin along the nephrostomy
      tract may alleviate postoperative pain. A unilateral Low thoracic paravertebral (PVB) block
      offers the option of providing extendable perioperative pain relief without the above side
      effects or the physiologic derangement associated with local anesthetics in the central
      neuraxial space.

      The aim of this study is to determine whether ultrasound guided low thoracic paravertebral
      block effective post-operative analgesia as compared to peritubal infiltration analgesia in
      patients undergoing percutaneous nephrolithotomy.

      Main outcome measures: The primary endpoint is postoperative opioid consumption. Secondary
      endpoints are visual analogue pain scores, opioid related side effects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>First 24 hours total opioid consumption</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual analog pain score</measure>
    <time_frame>postoperative first hour</time_frame>
    <description>Post operative pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain) at first hour postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog pain score</measure>
    <time_frame>postoperative second hour</time_frame>
    <description>Post operative pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain) at second hour postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog pain score</measure>
    <time_frame>postoperative 4th hour</time_frame>
    <description>Post operative pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain) at 4th hour postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog pain score</measure>
    <time_frame>postoperative 8th hour</time_frame>
    <description>Post operative pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain) at 8th hour postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog pain score</measure>
    <time_frame>postoperative 12th hour</time_frame>
    <description>Post operative pain will be evaluated with a Visual Analogue Scale (VAS)score of 0-10 (0= no pain and 10= worst imaginable pain) at 12th hour postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog pain score</measure>
    <time_frame>postoperative 24th hour</time_frame>
    <description>Post operative pain will be evaluated with a Visual Analogue Scale (VAS)score of 0-10 (0= no pain and 10= worst imaginable pain) at 24th hour postoperatively</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Percutaneous Nephrolithotomy</condition>
  <arm_group>
    <arm_group_label>Low thoracic paravertebral block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>T8-T9 Ultrasound guided paravertebral block with 20 ml %0,25 bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Peritubal infiltration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Peritubal infiltration with 20 ml %0,25 bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No drug</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>20 ml %0,25 bupivacaine</description>
    <arm_group_label>Low thoracic paravertebral block</arm_group_label>
    <arm_group_label>Peritubal infiltration</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <arm_group_label>Low thoracic paravertebral block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologist's physiologic state I-III patients undergoing
             percutaneous nephrolithotomy

        Exclusion Criteria:

          -  chronic pain

          -  bleeding disorders

          -  renal or hepatic insufficiency

          -  patients on chronic non-steroidal anti-inflammatory medications

          -  emergency cases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ali Ahiskalioglu, Ass.Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Ataturk University Anesthesiology and Reanimation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ataturk University</name>
      <address>
        <city>Yakutiye</city>
        <state>Erzurum</state>
        <zip>25100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Kirac M, Tepeler A, Bozkurt OF, Elbir F, Ozluk C, Armagan A, Unsal A, Biri H. The efficacy of bupivacaine infiltration on the nephrostomy tract in tubeless and standard percutaneous nephrolithotomy: a prospective, randomized, multicenter study. Urology. 2013 Sep;82(3):526-31. doi: 10.1016/j.urology.2013.02.083. Epub 2013 Jul 4.</citation>
    <PMID>23831069</PMID>
  </reference>
  <reference>
    <citation>Ak K, Gursoy S, Duger C, Isbir AC, Kaygusuz K, Ozdemir Kol I, Gokce G, Mimaroglu C. Thoracic paravertebral block for postoperative pain management in percutaneous nephrolithotomy patients: a randomized controlled clinical trial. Med Princ Pract. 2013;22(3):229-33. doi: 10.1159/000345381. Epub 2012 Dec 14.</citation>
    <PMID>23257888</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2016</study_first_submitted>
  <study_first_submitted_qc>May 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2016</study_first_posted>
  <last_update_submitted>October 10, 2016</last_update_submitted>
  <last_update_submitted_qc>October 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ataturk University</investigator_affiliation>
    <investigator_full_name>Ahmet Murat Yayik</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Postoperative Analgesia</keyword>
  <keyword>Peritubal infiltration</keyword>
  <keyword>Ultrasound guided low thoracic paravertebral block</keyword>
  <keyword>Percutaneous Nephrolithotomy pain</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

